Comera Life Sciences Holdings, Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was USD 0.13631 million compared to USD 0.234922 million a year ago. Net loss was USD 2.15 million compared to USD 3.08 million a year ago. Basic loss per share from continuing operations was USD 0.1 compared to USD 0.2 a year ago.
For the nine months, sales was USD 0.84428 million compared to USD 0.476982 million a year ago. Net loss was USD 6.05 million compared to USD 15.04 million a year ago. Basic loss per share from continuing operations was USD 0.31 compared to USD 1.85 a year ago.